REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,612 | +363.2% | 93,711 | +2642.5% | 0.00% | +100.0% |
| Q2 2023 | $348 | +11.9% | 3,417 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $311 | +139.2% | 3,417 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $130 | -99.8% | 3,417 | 0.0% | 0.00% | – |
| Q3 2022 | $86,000 | -17.3% | 3,417 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $104,000 | -7.1% | 3,417 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $112,000 | +24.4% | 3,417 | 0.0% | 0.00% | – |
| Q4 2021 | $90,000 | -73.8% | 3,417 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $344,000 | -28.9% | 3,417 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $484,000 | +41.9% | 3,417 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $341,000 | -19.2% | 3,417 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $422,000 | +26.7% | 3,417 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $333,000 | -37.5% | 3,417 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $533,000 | +8.1% | 3,417 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $493,000 | -29.5% | 3,417 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $699,000 | +119.1% | 3,417 | -14.0% | 0.00% | +100.0% |
| Q3 2019 | $319,000 | -14.9% | 3,975 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $375,000 | – | 3,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |